Ana Valientes Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 14708 Hawthorne Blvd, Lawndale, CA 90260 Phone: 424-220-8911 |
Mr. Henrick Macalintal, DPT Physical Therapist Medicare: May Accept Medicare Assignments Practice Location: 14708 Hawthorne Blvd., Lawndale, CA 90260 Phone: 800-659-9311 Fax: 562-989-6516 |
Krista King, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4726 W 162nd St, Lawndale, CA 90260 Phone: 310-990-1227 |
Advanced Rehab Therapy, Inc Physical Therapist - Orthopedic Medicare: Not Enrolled in Medicare Practice Location: 14708 Hawthorne Blvd, Lawndale, CA 90260 Phone: 800-659-9311 |
Dan E Chatwin Physical Therapist Medicare: Medicare Enrolled Practice Location: 14708 Hawthorne Blvd, Lawndale, CA 90260 Phone: 310-676-4151 Fax: 310-676-4169 |
Motion Plus Aquatic & Therapy Center Physical Therapist Medicare: Medicare Enrolled Practice Location: 14708 Hawthorne Blvd, Lawndale, CA 90260 Phone: 800-659-9311 Fax: 562-989-6516 |
Mr. Brian Alisoso Abellana, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 14708 Hawthorne Blvd, Lawndale, CA 90260 Phone: 424-220-8911 |
News Archive
A new study has highlighted that while much is known about the ever increasing uptake of antidepressant medications around the world, there is very little evidence on safe and effective approaches to discontinuing treatment.
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced positive interim results from its ongoing Phase 2 clinical trial with aldoxorubicin for the treatment of unresectable glioblastoma multiforme (GBM), a deadly form of brain cancer.
Data Advantage, LLC announced today the Top 100 Hospital: Best in Value Hospitals™ list from the 2009-2010 Hospital Value Index™, the first and only national study on U.S. hospitals and the value of care they provide.
Marketed under the trade name Vitango® and now available from pharmacies, the product is a special extract of a highly resilient plant called Golden Root (Rhodiola rosea) that grows in the freezing conditions of Northern Europe and Asia's mountain peaks.
Gilead Sciences, Inc. has announced receipt of a Paragraph IV Certification Notice Letter advising that Teva Pharmaceuticals submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA) requesting permission to manufacture and market a generic version of Atripla (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg). Atripla is currently sold in the United States through a joint venture between Bristol-Myers Squibb and Gilead.
› Verified 8 days ago